Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationSutter Care at Home
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Book Appointment
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Book Appointment
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • Sutter Care at Home
  • Research
  • Investigators
  • Stewart Cooper
Content

Investigator Stewart Cooper, M.D.

Stewart Cooper, M.D.

View profile  
 Dr. Cooper studies molecular and genetic changes underlying liver diseases including hepatitis B and C, and he uses genomic and proteomic approaches to uncover new therapeutic targets for the hepatitis virus. Current research in the Cooper lab includes investigations of how natural killer cells, T cells, and hybrid natural killer T cells may interact to clear hepatitis C, and how related sets of genes influence immune response. Dr. Cooper directs the Kalmanovitz Liver Immunology Laboratory at CPMC, and leads translational research to identify immunological influences on disease outcomes in patients with hepatitis C (including those undergoing liver transplantation).  Under Dr. Cooper’s leadership, validated biomarkers for liver and biliary diseases will be used to personalize treatment and help predict an individual’s response to therapy.


Sutter Health Research Enterprise
2340 Clay Street, 3rd Floor
San Francisco, CA, 94115
(415) 600-1020  
scooper@cpmcri.org

Primary Research Interests

  • Liver Diseases and Transplant

Related Clinical Trials

Eiger Hepatitis D Study

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV (LIMT-2)

Investigators: Stewart Cooper M.D., Raphael Merriman MD, Kidist Yimam MD

Status: Active, Recruiting

The Sutter Health Network of Care
Expertise to fit your needs
Primary Care

Check-ups, screenings and sick visits for adults and children.

Specialty Care

Expertise and advanced technologies in all areas of medicine.

Emergency Care

For serious accidents, injuries and conditions that require immediate medical care.

Urgent Care

After-hours, weekend and holiday services.

Walk-In Care

Convenient walk-in care clinics for your non-urgent health needs.

  • Contact Us
  • Find Doctors
  • Find Locations
  • Book Appointment
  • Request Medical Records
  • Donate Now
Sign in to My Health Online

Billing and Insurance

  • Pay a Bill
  • Accepted Health Plans
  • Estimate Costs
  • Medicare Advantage

About Sutter

  • About Our Network
  • Community Benefit
  • Annual Report
  • News and Media

Our Team

  • For Employees
  • For Medical Professionals
  • For Vendors
  • For Volunteers

Careers

  • Jobs at Sutter
  • Physician Jobs
  • Graduate Medical Education

Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

  • ADA Accessibility
  • Privacy
  • Do Not Sell My Personal Information
  • LinkedIn Opens new window
  • YouTube Opens new window
  • Facebook Opens new window
  • Twitter Opens new window
  • Instagram Opens new window
  • Glassdoor Opens new window

Cookie Policy

We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

Privacy Policy Cookie Preferences